Skip to main content

What the FDA labels say about taking them together

Enzalutamide and phenobarbital

Enzalutamide's FDA label (Xtandi) of May 25, 2021 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name enzalutamide.

Check it at the source: the enzalutamide FDA label on DailyMed (effective July 28, 2026, Astellas Pharma US, Inc.); the phenobarbital FDA label on DailyMed (effective August 27, 2026).

What does the enzalutamide label say about phenobarbital?

Xtandi label (Astellas Pharma US, Inc., May 25, 2021), drug interactions

Co-administration of strong CYP3A4 inducers (e.g., carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine) with XTANDI should be avoided if possible.

Source: FDA drug label (Xtandi, NDA213674), Astellas Pharma US, Inc., effective May 25, 2021 (SPL set 381cd215-78c9-4208-8595-7ae7a279b236), via openFDA

Source: FDA drug label (Xtandi), Astellas Pharma US, Inc., effective July 28, 2026 (SPL set b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf), via openFDA; the full label on DailyMed

What does the phenobarbital label say about enzalutamide?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name enzalutamide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Enzalutamide generic labelers
0Phenobarbital generic labelers
EnzalutamidePhenobarbital
Labeled forProstate cancerSeizures and epilepsy
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.213 per tablet 100 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?